Xeris Biopharma Holdings Inc. buy Oppenheimer Holdings Inc.
Start price
12.11.25
/
50%
€6.66
Target price
12.11.26
€15.55
Performance (%)
-18.53%
Price
28.05.26
€5.42
Summary
This prediction is currently active. The prediction for Xeris Biopharma Holdings Inc. disappoints with a performance of -18.53%. This prediction currently runs until 12.11.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | - | - |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $18.00 price target on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€8.51
29.10.25
29.10.25
€15.45
29.10.26
29.10.26
-36.25%
28.05.26
28.05.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€4.45
09.05.25
09.05.25
€6.24
09.05.26
09.05.26
22.54%
10.05.26
10.05.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.04
28.03.24
28.03.24
€4.62
28.03.25
28.03.25
154.90%
29.03.25
29.03.25